Trial Profile
Phase III clinical study of TY-0201 in patients with chronic atrial fibrillation -long-term study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Bisoprolol (Primary)
- Indications Atrial fibrillation
- Focus Adverse reactions; Registrational
- Sponsors Toa Eiyo
- 05 Jan 2017 Status changed from active, no longer recruiting to completed.
- 07 Jun 2016 New trial record